[Effect of dihydrobenzperidol on urinary excretion of 17-hydroxycorticosteroids, 3-methyl-4-hydroxymandelic acid 5-hydroxy-indoleacetic acid and uropepsin in patients with chronic gastric and duodenal ulcer].
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D001544:Benperidol / Q000494:pharmacology*; D002908:Chronic Disease; D004381:Duodenal Ulcer / Q000652:urine*; D010450:Endopeptidases / Q000652:urine; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine*; D008333:Mandelic Acids / Q000652:urine*; D013276:Stomach Ulcer / Q000652:urine*
D015065:17-Hydroxycorticosteroids; D008333:Mandelic Acids; D006897:Hydroxyindoleacetic Acid; D001544:Benperidol; D010450:Endopeptidases
Wpływ dehydrobenzoperidolu na wydalanie 17-hydroksysteroidów, kwasu 3-metoksy-4-hydroksymigdałowgo, kwasu 5-hydroksyindrolooctowego i uropepsyny u osób chorych na chorobe wrzodowa zoładka i dwunastnicy.